“Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates As Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy”. 2026. Pakistan Journal of Medical & Cardiological Review 5 (2): 1174-80. https://doi.org/10.66021/pakmcr903.